Loading company…
PROMISS Diagnostics developed a machine learning test to assess ovarian cancer risk from serum samples.
Founded in 2017 and based in Wauwatosa, US, PROMISS Diagnostics develops diagnostic tests for ovarian cancer. Its PROMISS test analyzes serum sample parameters with an algorithm to produce a score indicating the presence of ovarian cancer. In September 2019, the company raised USD 0.40 million in seed funding led by WARF Ventures, with Cream City Venture Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in